Avelas Biosciences Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
Avelas Biosciences General Information
Description
Developer of intraoperative imaging technology designed for cancer surgery and therapeutic intervention. The company's technology permits the real-time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides, enabling surgeons to avoid repeat surgeries and improve patient outcomes.
Contact Information
Website
www.avelasbio.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 290, La Jolla
- San Diego, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290, La Jolla
- San Diego, CA 92037
- United States
Avelas Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Feb-2021 | Completed | Clinical Trials - Phase 3 | |||
| 5. Accelerator/Incubator | 01-Jun-2019 | Completed | Clinical Trials - Phase 3 | |||
| 4. Later Stage VC | 01-Mar-2017 | Completed | Clinical Trials - Phase 3 | |||
| 3. Later Stage VC (Series C) | 18-Aug-2016 | Completed | Clinical Trials - Phase 3 | |||
| 2. Later Stage VC (Series B) | 10-Sep-2014 | $7.4M | $15.1M | Completed | Clinical Trials - General | |
| 1. Early Stage VC (Series A) | 06-Dec-2012 | $7.65M | $7.65M | Completed | Pre-Clinical Trials |
Avelas Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 7,080,540 | $0.001000 | 8% | $1.06 | $1.06 | 1x | $1.06 | 18.91% |
Avelas Biosciences Comparisons
Industry
Financing
Details
Avelas Biosciences Competitors (20)
One of Avelas Biosciences’s 20 competitors is Seno Medical, a Private Equity-Backed company based in San Antonio, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Seno Medical | Private Equity-Backed | San Antonio, TX | ||||
| Blaze Bioscience | Venture Capital-Backed | Seattle, WA | ||||
| Aviva Systems Biology | Formerly VC-backed | San Diego, CA | ||||
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA | ||||
| Kubtec Medical Imaging | Corporation | Stratford, CT |
Avelas Biosciences Patents
Avelas Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022081438-A1 | Methods of using selective delivery molecules | Inactive | 13-Oct-2020 | ||
| WO-2019204364-A1 | Compositions and methods for the selective delivery of therapeutic and imaging agents | Inactive | 16-Apr-2018 | ||
| WO-2019204363-A2 | Selective delivery of therapeutic and imaging agents | Inactive | 16-Apr-2018 | ||
| WO-2019204363-A3 | Selective delivery of therapeutic and imaging agents | Inactive | 16-Apr-2018 | ||
| JP-2023102271-A | Ratiometric fluorescence imaging method | Pending | 07-Apr-2017 | C09K11/06 |
Avelas Biosciences Signals
Avelas Biosciences Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| 120 Capital | Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Pharmstandard (Pharmaceuticals) | Corporation | Minority | ||
| phs Ventures | Venture Capital | Minority |
Avelas Biosciences FAQs
-
When was Avelas Biosciences founded?
Avelas Biosciences was founded in 2008.
-
Where is Avelas Biosciences headquartered?
Avelas Biosciences is headquartered in San Diego, CA.
-
What is the size of Avelas Biosciences?
Avelas Biosciences has 11 total employees.
-
What industry is Avelas Biosciences in?
Avelas Biosciences’s primary industry is Diagnostic Equipment.
-
Is Avelas Biosciences a private or public company?
Avelas Biosciences is a Private company.
-
What is Avelas Biosciences’s current revenue?
The current revenue for Avelas Biosciences is .
-
How much funding has Avelas Biosciences raised over time?
Avelas Biosciences has raised $37.6M.
-
Who are Avelas Biosciences’s investors?
MedTech Innovator, 120 Capital, Alexandria Venture Investments, Pharmstandard (Pharmaceuticals), and phs Ventures are 5 of 9 investors who have invested in Avelas Biosciences.
-
Who are Avelas Biosciences’s competitors?
Seno Medical, Blaze Bioscience, Aviva Systems Biology, Actym Therapeutics, and Kubtec Medical Imaging are some of the 20 competitors of Avelas Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process